By: Janet B. Linn , Tarter Krinsky & Drogin LLP This article addresses how counsel for a generic drug company should prepare for patent litigation under the Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch...

By: John DeFosse FRIED FRANK, HARRIS, SHRIVER & JACOBSON LLP THIS ARTICLE EXPLAINS THE STRATEGIC AND PRACTICAL considerations associated with filing a motion to dismiss claims of patent infringement under Rule 12(b)(6) of the Federal Rules of Civil...

By: Roberta Jacobs-Meadway and Roger LaLonde, ECKERT SEAMANS CHERIN & MELLOTT, LLC BEFORE SENDING A TRADEMARK CEASE AND DESIST LETTER on behalf of a client, it is imperative to conduct due diligence and to carefully consider the content and tone...

By: Rebecca K. Myers , Vandenberg & Feliu, LLP LEXIS PRACTICE ADVISOR RESEARCH PATH: Business & Commercial > Commercial Contracts > Confidentiality and Non-Disclosure Agreements > Practice Notes > Confidentiality Agreements CONFIDENTIALITY...

By: Amy M. Gordon, Ann Killilea, Michael G. Morgan, Susan M. Nash, and Angela M. Stockbridge , McDermott Will & Emery LLP. The U.S. Department of Health and Human Services (HHS) recently issued guidance under the Health Insurance Portability and...